MANAGEMENT OF A REEVE'S MUNTJAC ( MUNTIACUS REEVESI) WITH SEIZURES USING LEVETIRACETAM

J Zoo Wildl Med. 2017 Dec;48(4):1197-1199. doi: 10.1638/2016-0282.1.

Abstract

This report describes the diagnosis and management of idiopathic epilepsy in a 4-yr-old intact female Reeve's muntjac ( Muntiacus reevesi). The patient was initially witnessed to have isolated paroxysmal events consistent with epileptic seizures (altered consciousness, lateral recumbency, tonic/clonic movement of limbs) lasting less than 3 min with an immediate return to normal consciousness. The seizure frequency increased to >3 seizures within 24 hr and phenobarbital 3 mg/kg orally every 12 hr was started. Because of continued epileptic seizures and low serum phenobarbital levels, the dose was increased until significant elevations of aspartate aminotransferase (AST) and alkaline phosphatase (ALP) were detected. Levetiracetam 40 mg/kg orally every 12 hr was initiated and the phenobarbital was weaned and discontinued. One breakthrough seizure has been witnessed in the 10 mo since starting levetiracetam.

Keywords: Levetiracetam; Muntiacus reevesi; Reeve's muntjac; phenobarbital; seizure.

Publication types

  • Case Reports

MeSH terms

  • Animals
  • Anticonvulsants / therapeutic use*
  • Epilepsy / diagnosis
  • Epilepsy / drug therapy
  • Epilepsy / veterinary*
  • Female
  • Levetiracetam / therapeutic use*
  • Muntjacs*

Substances

  • Anticonvulsants
  • Levetiracetam